Unlock stock picks and a broker-level newsfeed that powers Wall Street.
33.24
+1.72
+(5.46%)
At close: 4:00:01 PM EDT
32.99
-0.25
(-0.75%)
After hours: 6:14:49 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 6 | 5 | 6 | 7 |
| Avg. Estimate | -0.29 | -0.25 | -0.76 | 0.71 |
| Low Estimate | -0.42 | -0.38 | -1.35 | 0 |
| High Estimate | -0.18 | -0.11 | 0.08 | 1.71 |
| Year Ago EPS | -0.32 | -0.1 | -0.96 | -0.76 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 12 | 12 | 21 | 19 |
| Avg. Estimate | 192.61M | 244.54M | 1.02B | 1.54B |
| Low Estimate | 183.29M | 215M | 920M | 1.22B |
| High Estimate | 207.6M | 317.25M | 1.16B | 1.88B |
| Year Ago Sales | 93.99M | 186.52M | 627.24M | 1.02B |
| Sales Growth (year/est) | 104.93% | 31.11% | 63.32% | 50.37% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.32 | -0.42 | -0.6 | -0.34 |
| EPS Actual | -0.32 | -0.1 | -0.68 | 0.14 |
| Difference | -0 | 0.32 | -0.08 | 0.49 |
| Surprise % | -0.41% | 75.98% | -12.80% | 140.58% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.29 | -0.25 | -0.76 | 0.71 |
| 7 Days Ago | -0.26 | -0.31 | -0.93 | 0.7 |
| 30 Days Ago | -0.31 | -0.31 | -0.75 | 1.06 |
| 60 Days Ago | -0.31 | -0.31 | -0.75 | 1.15 |
| 90 Days Ago | -0.29 | -0.28 | -0.61 | 1.15 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 2 | 1 |
| Up Last 30 Days | 1 | 1 | 2 | 2 |
| Down Last 7 Days | 2 | 1 | 2 | -- |
| Down Last 30 Days | 1 | 1 | 3 | 2 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| LEGN | 8.33% | -150.00% | 20.39% | 192.74% |
| S&P 500 | 6.69% | 6.80% | 9.98% | 14.34% |
Upgrades & Downgrades
| Maintains | Morgan Stanley: Overweight to Overweight | 3/17/2025 |
| Reiterates | Guggenheim: Neutral to Neutral | 3/12/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 3/12/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/23/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/22/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/21/2025 |
Related Tickers
ACLX Arcellx, Inc.
67.23
+10.76%
RVMD Revolution Medicines, Inc.
34.60
+2.91%
CRNX Crinetics Pharmaceuticals, Inc.
31.39
+2.51%
RARE Ultragenyx Pharmaceutical Inc.
35.37
+4.52%
INSM Insmed Incorporated
73.44
+2.00%
APGE Apogee Therapeutics, Inc.
37.83
+6.23%
AKRO Akero Therapeutics, Inc.
41.95
+8.57%
APLS Apellis Pharmaceuticals, Inc.
23.00
+1.41%
BPMC Blueprint Medicines Corporation
90.01
+4.74%
CYTK Cytokinetics, Incorporated
40.25
+7.33%